Canada In-vitro Colorectal Cancer Screening Tests Market Size & Outlook
Canada in-vitro colorectal cancer screening tests market, 2018-2030 (US$M)
Related Markets
Canada in-vitro colorectal cancer screening tests market highlights
- The Canada in-vitro colorectal cancer screening tests market generated a revenue of USD 86.7 million in 2023 and is expected to reach USD 111.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 3.6% from 2024 to 2030.
- In terms of segment, fecal occult blood tests was the largest revenue generating test type in 2023.
- Biomarker tests is the most lucrative test type segment registering the fastest growth during the forecast period.
In-vitro colorectal cancer screening tests market data book summary
| Market revenue in 2023 | USD 86.7 million |
| Market revenue in 2030 | USD 111.2 million |
| Growth rate | 3.6% (CAGR from 2023 to 2030) |
| Largest segment | Fecal occult blood tests |
| Fastest growing segment | Biomarker tests |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fecal Occult Blood Tests, Biomarker tests, CRC DNA Screening Tests |
| Key market players worldwide | Abbott Laboratories, Epigenomics AG, Beckman Coulter, Eiken Chemical Co Ltd, Sysmex Corp, Siemens Healthineers AG ADR, Quest Diagnostics Inc, OncoCyte Corp, Merck KGaA, Kyowa Kirin Co Ltd, R-Biopharm, Immunostics, Randox |
Other key industry trends
- In terms of revenue, Canada accounted for 9.6% of the global in-vitro colorectal cancer screening tests market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. in-vitro colorectal cancer screening tests market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 111.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Colorectal Cancer Screening Tests Market Scope
In-vitro Colorectal Cancer Screening Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada in-vitro colorectal cancer screening tests market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro colorectal cancer screening tests market will help companies and investors design strategic landscapes.
Fecal occult blood tests was the largest segment with a revenue share of 81.55% in 2023. Horizon Databook has segmented the Canada in-vitro colorectal cancer screening tests market based on fecal occult blood tests, biomarker tests, crc dna screening tests covering the revenue growth of each sub-segment from 2018 to 2030.
- Canada In-vitro Colorectal Cancer Screening Tests Test Type Outlook (Revenue, USD Million, 2018-2030)
- Fecal Occult Blood Tests
- Guaiac FOB Stool Test
- Immuno-FOB Agglutination Test
- Lateral Flow Immuno-FOB Test
- Immuno-FOB ELISA Test
- Biomarker tests
- Tumor M2-PK Stool Test
- Transferrin Assays
- CRC DNA Screening Tests
- Methylated Gene Testing
- Panel DNA Tests
- Fecal Occult Blood Tests
Reasons to subscribe to Canada in-vitro colorectal cancer screening tests market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada in-vitro colorectal cancer screening tests market databook
-
Our clientele includes a mix of in-vitro colorectal cancer screening tests market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada in-vitro colorectal cancer screening tests market , including forecasts for subscribers. This country databook contains high-level insights into Canada in-vitro colorectal cancer screening tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada in-vitro colorectal cancer screening tests market size, by test type, 2018-2030 (US$M)
Canada In-vitro Colorectal Cancer Screening Tests Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
